2015 HSC Section 1 Book of Articles

IV.

Rhinology Boghani Z, Husain Q, Kanumuri VV, et al. Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases. Laryngoscope . 2013; 123(4):859-869. EBM level 3a......................................................................................................................111-121 Summary: This article presents a systematic review of English-language articles reporting on results of surgical management of juvenile nasopharyngeal angiofibroma published between 1990 and 2012. The authors separately analyze those studies reporting individual patient data (mainly case reports and small case series) and aggregate patient data (larger case series and prospective studies). Brietzke, SE, Shin JJ, Choi S, et al. Clinical consensus statement: pediatric chronic rhinosinusitis. Otolaryngol Head Neck Surg . 2014; 151(4):542-553. EBM level 5.......................................................................................................................122-133 Summary: This article is a summary of an expert panel consensus which was convened to help optimize the diagnosis and management of pediatric chronic rhinosinusitis (PCRS). The conclusions were assembled after using a Delphi method survey of nine experts and can be categorized as topics relevant to the definition and diagnosis of PCRS, medical management, adenoiditis/adenoidectomy, and endoscopic sinus surgery and turbinate surgery. Lindstrand A, Bennet R, Galanis I, et al. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine. Pediatrics . 2014; 134(6):e1528-e1536. EBM level 3..............................................................................................................134-142 Summary: This is a population study examining the risk of hospitalization for pneumonia, sinusitis, and empyema following vaccination with pneumococcal conjugate vaccines PCV7 and PCV13. This study shows reduced risk of hospitalization for pneumonia in children under age 5 years and sinusitis in children under 2 years. Olarte L, Hulten KG, Lamberth L, et al. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated Streptococcus pneumoniae in children. Pediatr Infect Dis J . 2014; 33(10):1033-1036. EBM level 3..............................................143-146 Summary: This is a retrospective study of 91 pediatric patients who underwent endoscopic sinus surgery and S. pneumoniae was identified via intraoperative culture. Comparison was made of the serotype of S. pneumoniae identified before and after 13-valent pneumococcal conjugate vaccine (PCV13) vaccinations were implemented. Following the introduction of PCV13, the rate of isolation of S. pneumoniae decreased, particularly of serotype 19A.